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There have been recent indications that AIDS’ primacy amongst global health issues 
may be under threat. In this article we examine a new response to this perceived threat 
to have emerged from the AIDS policy community: the ‘AIDS plus MDGs’ approach 
which argues that the AIDS response (the focus of MDG6) is essential to achieving the 
other MDG targets by 2015, and which stresses the two-way relationship between 
AIDS and other development issues. In framing AIDS in this way, the AIDS plus 
MDGs approach draws on a well-established narrative on the existence of a ‘virtuous 
circle’ between health and development, but at the same time makes some important 
concessions to critics of the AIDS response. This article - the first critical academic 
analysis of the AIDS plus MDGs approach – uses this case to illuminate aspects of the 
use of framing in global health, shedding light both on the extent to which new 
framings draw upon established ‘common sense’ narratives but also on the ways in 
which framers must adapt to the changing material and ideational context in which they 
operate. 
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Introduction
1 
It has become almost a cliché to state that AIDS is not simply a health issue but rather a 
multisectoral one. Indeed, this insight is generally put forward as one of the key reasons for 
the creation of the Joint United Nations Programme on HIV/AIDS (UNAIDS) in 1996 which 
took over the role of co-ordinating the UN-wide response to HIV and AIDS from the WHO, a 
body which had previously been widely criticised for its narrow, biomedically-focussed 
response to the epidemic (e.g. Das and Samarasekera 2008, Lisk 2010, pp. 22-3). Whilst 
many national ministries of health were initially resistant to adopting a multisectoral 
approach, the argument that the full engagement of all sectors of society is a prerequisite for 
an effective AIDS response was forcefully made throughout the 1990s, and widely 
institutionalised through the creation of National AIDS Commissions (NACs).
2
 Linked to 
these ideas about the peculiarly multisectoral nature of AIDS are ongoing discussions 
concerning ‘AIDS exceptionalism’.  Proponents have argued that the challenge of AIDS 
requires an exceptional response, which in turn has positive spill-over effects for other global 
health issues and for development more generally. Others, however, have argued that the 
huge focus on AIDS has had a distorting effect upon global health and development priorities 
and that it should be normalized and treated like any other disease.
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 This debate continues.  
One explanation which has been put forward in the literature for the degree of 
prioritisation which AIDS has enjoyed over the last 15 years is that the AIDS policy 
community have been particularly successful at framing and re-framing the issue at various 
times and in various ways to capture high-level political attention (Shiffman 2009, Rushton 
2010). As Shiffman (2009, p. 609) notes, ‘HIV/AIDS has been framed as a public health 
problem, a development issue, a humanitarian crisis, a human rights issue and a threat to 
security.’ Whilst all these arguments have indeed been made to motivate and justify 
responses to AIDS in the Millennium Development Goals (MDG) period (2000-2015), this 
paper views the linkage between AIDS and development as having been a particularly 
resilient and powerful framing of the issue, and one of the major reasons for its central place 
in contemporary global health governance. 
There have, however, been recent indications that AIDS’ primacy amongst global 
health issues may be under threat. It was widely noted following the MDG review summit 
held in New York in September 2010 that momentum seemed to be shifting towards a greater 
emphasis on other health issues such as malaria, child mortality and maternal mortality, 
potentially undermining political and financial commitment to the fight against AIDS.  In this 
article we examine a new response to this perceived threat to have emerged from the AIDS 
policy community: the ‘AIDS plus MDGs’ approach which argues that the AIDS response 
(the focus of MDG6) is essential to achieving the other MDG targets by 2015 (UNAIDS 
2010b, p.1) by stressing the two-way relationship between AIDS and other development 
issues. We see this as a rearguard action, involving the (re)framing of AIDS as a development 
issue through the forwarding of the claim that there is a mutually reinforcing relationship 
between AIDS and development, which infers positive external effects from AIDS 
investments to other areas of development and vice versa. In framing AIDS in this way, the 
AIDS plus MDGs approach draws on (or ‘resonates with’) a well-established narrative on the 
existence of a ‘virtuous circle’ between health and development whilst at the same time 
making some important concessions to critics of the AIDS response. However, the framing of 
future responses to AIDS in the AIDS plus MDGs approach presents it as necessarily co-
dependent on other structural, social and developmental investments and needs (such as in 
terms of education or poverty alleviation), casting the AIDS-development dynamic in terms 
of a two-way, interdependent relationship. In this respect, it represents a subtle yet significant 
shift from the framing of the disease associated with the decade following the initiation of the 
MDGs. 
As the first critical academic analysis of the AIDS plus MDGs approach, we 
specifically aim to illuminate such use of framing in global health, shedding light both on the 
extent to which new framings draw upon established ‘common sense’ narratives but also on 
the ways in which framers must simultaneously adapt to the changing material and ideation 
context in which they operate. Consequently, the paper serves to ensure an original and 
significant contribution to knowledge which will extend and enhance existing literature on 
the framing of AIDS as a development issue in the context of contemporary studies of global 
health governance (GHG).  
The article proceeds in two stages. We begin by briefly discussing the historical 
framing of health (and subsequently AIDS) as an economic development issue, and the 
centrality of the idea of vicious and virtuous circles to this narrative. Indeed, the conventional 
wisdom that health and underdevelopment form a vicious circle – in which poor health 
(including AIDS) increases poverty and hampers economic development (which in turn 
undermines health) – or a virtuous circle – in which investing in health can promote 
productivity and economic growth, further improving health and opening up possibilities for 
further increased health investment – has become widely accepted as common sense. 
However, we suggest that the MDG ‘period’ has been characterised by policy approaches that 
have laid greater stress on health investments as the point of entry for solving the wider 
problem of development and poverty alleviation, or as the means of making a vicious circle 
virtuous. Indeed, the ways in which this idea has been operationalised in practice, including a 
focus on specific diseases, has been subjected to considerable criticism, not least because of 
the causal weight and significance that has been attached to the role of ‘select’ health 
investments as a route out of poverty. AIDS – the largest ‘select’ single-disease programme 
by far – has borne the brunt of much of this criticism.  
The second part of the paper moves to a detailed analysis of two of the key documents 
setting out the ‘AIDS plus MDGs’ approach. It notes that whilst in many respects the 
approach represents a continuation of established health-development arguments (including 
the idea of a virtuous circle) there is also significant evidence of adjustment to the framing of 
AIDS, and that the AIDS plus MDGs discourse responds to some of the criticisms of 
previous approaches and seeks to promote a more holistic vision of the links between AIDS 
and development. In our conclusion we offer some thoughts on what the AIDS plus MDGs 
approach can tell us about the changing landscape of global health governance, the position 
of AIDS within it, and the use of framing in global health.  
Health, poverty and development: establishing a narrative 
We begin with a discussion of how health came to be framed as a key causal factor in 
producing and reproducing poverty and underdevelopment. Framing poor health as a 
development issue – or, more accurately, as an issue linked to economic development and 
economic growth – has been a feature of the international development discourse for many 
decades. A seminal moment in the elevation of this narrative to the top tier of global 
development policy was the World Bank’s hugely influential 1993 World Development 
Report Investing in Health. Not only did the report focus exclusively on health, it suggested 
that poor health was a primary obstacle to development and justified investment in health in 
terms of poverty alleviation, net economic return on  investment, and in terms of horizontal 
spill-overs of such investments to other areas of development. Crucial to this case was the 
idea of the potential for a virtuous circle between health spending, productivity and economic 
development. Investments in health were held to be cost-effective (as compared to other 
development stimuli), and justifiable in terms of the economic and social returns: 
Good health, as people know from their own experience, is a crucial part of well-being, 
but spending on health can also be justified on purely economic grounds. Improved 
health contributes to economic growth in four ways: it reduces production losses caused 
by worker illness; it permits the use of natural resources that had been totally or nearly 
inaccessible because of disease; it increases the enrollment of children in school and 
makes them better able to learn; and it frees for alternative uses resources that would 
otherwise have to be spent on treating illness. The economic gains are relatively greater 
for poor people, who are typically most handicapped by ill health and who stand to gain 
the most from the development of underutilized natural resources. (World Bank 1993, 
17-8). 
The virtuous circle narrative subsequently gained traction, coming to colonize the discourses 
of other high-profile development institutions, with the health-to-economic development 
linkage appearing increasingly natural and obvious. UNDP’s 1996 Human Development 
Report, for example, noted that: 
Human development requires, among other things, considerable investment in education, 
health and nutrition. The result is a healthier and better educated population that is 
capable of being economically more productive. Indeed, many modern growth theories 
explain economic growth primarily in terms of expanded human capital... The links 
between human development and economic growth can make them mutually reinforcing. 
When the links are strong, they contribute to each other. But when the links are weak or 
broken, they can become mutually stifling as the absence of one undermines the other 
(UNDP 1996, 66). 
For us, a critical juncture in the transformation of this narrative into a ‘common sense’ driver 
of global health and development policy occurred with adoption of the MDGs. Over the first 
decade of the twenty-first century the MDGs have become effectively synonymous with 
‘development’, at least in global policy discourse. Concepts such as human development, 
poverty alleviation (which forms the focus of MDG1) and economic development have been 
collapsed into a more general notion of ‘development policy’. Such has been the power of the 
MDGs in channelling global development efforts that many of the previous debates over 
what development means (debates which continue within academia and civil society) have 
been dramatically downplayed. As Ollila (2005) points out, the policy space for other 
approaches to both health and development have shrunk as a result. The UN system, 
multilateral institutions and other actors have aligned themselves to the MDGs as an all 
encompassing multisectoral project, or the only development game in town. 
Whilst the MDGs rest implicitly upon the virtuous circle idea that investing in health 
(and other key areas) can kick-start economic growth in developing countries, that argument 
was set out far more clearly in the 2001 report of the WHO-backed Commission on 
Macroeconomics and Health (CMH), the result of two years’ work by a committee of 18 
individuals (many of whom were economists and/or and former IFI personnel) under the 
chairmanship of Jeffrey Sachs, the influential Harvard (and later Columbia University) 
economist. The report represents a natural and conscious counterpart to the MDGs 
themselves, not least because it economically justified the selection of specific – or ‘select’ – 
interventions in global health and the setting of targets and measures (vis-à-vis population 
health and impact on economic measures such as GDP), and did so in the direction of poverty 
elimination and development. Indeed, the CMH was in part set up to bolster international 
support for the wider MDG process, and the report makes constant reference to them, but 
with health framed in terms of a special relationship with macroeconomic change. Moreover, 
Sachs later became the Director (2002-06) of the UN Millennium Project and Special 
Advisor to the UN Secretary General on the MDGs. The CMH’s report’s shares a common 
approach with previous framings of health as a target of investment which can lead to 
improvements in economic productivity, and thereby economic development whilst also 
presenting poor health as an obstacle to development: the vicious/virtuous circle argument. 
Like the World Bank’s 1993 report, the CMH sought to place health investments at the centre 
of global development policy.  
At the heart of the CMH report are a series of assumptions which have direct 
implications for global health and, indeed, our later discussion of HIV/AIDS within this 
broad policy landscape. These assumptions, and their implications, were systematically 
deconstructed in Alison Katz’s seminal pair of articles for the International Journal of Health 
Services (Katz 2004, 2005). Katz’s textual analysis of the CMH was prescient in that it 
anticipated the manner in which the CMH would interrelate with and justify the 
operationalisation of MDG6 (in particular) under vertical disease-specific programmes, and 
the process whereby the framings of such interventions in terms of economic development 
would come to constitute a ‘blueprint’ for global health policy making (Katz 2004, 752). 
Among other things, Katz questions the basic virtuous/vicious circle ‘common sense’ which 
underpins the CMH, namely the supposed obviousness of a reciprocal causal dynamic 
between health, poverty and human development. For Katz, ‘development’ within the CMH 
report is a thinly-veiled shorthand for the objective of economic growth under conditions of 
neoliberal globalised capitalism, and she argues that within the Sachs commission’s framing 
of the virtuous/vicious circle too much importance (or causal force) is ascribed to health with 
respect to poverty: 
The relationship between health and poverty is two way but it is not symmetric. Poverty 
is the single most important determinant of poor health. But poor health is very far from 
being the single most important determinant of poverty. Poor health exacerbates existing 
poverty. Both the vicious cycle and the “virtuous” cycle of health and poverty are 
misleading images, as they imply equal weight of the two poles of health and economic 
development. (Katz 2004, p.752, original emphasis) 
Subsequently, Katz highlights the existence of alternative and arguably more significant 
determinants of poverty in developing countries than health. These include the skewed 
international terms of trade (2005, pp. 179-80); the burden of developing country debt as 
compared to aid receipts and the failure of the Highly Indebted Poor Country initiative (p. 
179); and western intervention (both military and economic) in such countries (p. 182). Thus, 
she argues, poor health should be viewed as only one outcome of, rather than principal driver 
of, these wider relations and structures (p. 176), and whilst investing in health will benefit the 
populations of developing countries it will not succeed in fundamentally addressing the 
problems of poverty and underdevelopment unless some of the other (and more powerful) 
root causes are also addressed.  
Another of Katz’s critiques, which has also been widely echoed by others (e.g. 
Faubion et al. 2011), is that despite the claims about health investments as a route out of 
poverty, the CMH in practice prioritises investment in specific diseases rather than a more 
holistic approach to public health, such as investments in sanitation and clean drinking water, 
which have been recognised to play a long-term, and dramatic role in improving population 
health. The assumption that short-term ‘vertical’ select interventions will provide the key to 
economic development belies the fact that interventions outside the healthcare system (for 
example in basic public health and other infrastructure) will prove far more effective in 
lowering the disease burdens suffered in developing countries, and that basic health is more 
forcefully determined by wider ‘socio-economic, political and cultural variables’ (Katz 2004, 
p. 761). It also moves attention away from ‘horizontal’ efforts aimed at strengthening health 
systems. For Katz, the specific disease-focussed, short-term, technological and biomedical 
nature of investments recommended by the CMH (and which have indeed tended to be 
prioritised in pursuit of meeting the MDGs), are ultimately neither as sustainable nor as 
effective as the obvious (but unfashionable) alternatives. The point is that it is not only 
‘investing in health’ that matters, and that investing in select diseases matters less. Whilst for 
Katz, and indeed for us, investments in select diseases are admirable in their own right, and 
were surely needed at the turn of the millennium as they are now, the real problem lies in the 
belief that they can serve the basis for a health-to-development strategy, the basic 
assumptions of which are already deeply flawed.  Furthermore, the ways in which health 
investments are targeted was also to have a huge impact on the manner in which poverty and 
underdevelopment were addressed in the MDG process to date. 
Crucially for our argument here, the MDGs placed AIDS in a privileged position vis-
à-vis other global health issues and even other ‘select’ diseases. Although the MDGs set out 
measurable targets in respect of three health issues: infant mortality (MDG4); maternal 
mortality (MDG5), and HIV/AIDS, malaria, TB and ‘other diseases’ (MDG6), of these three 
so-called ‘health MDGs’ it is clear that (notwithstanding a renewed vigour in the area of 
childhood vaccination, reflected in the recent substantial refinancing of GAVI) HIV/AIDS 
has received by far the most sustained focus and has captured a huge proportion of the global 
health spend,
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 often at the expense of the ‘competing’ health MDGs (not to mention those 
health issues not covered by the MDGs).  
For us, one of the most interesting results of this focus on AIDS has been the 
transposition of the broader ‘common sense’ narrative of health-to-development to a new 
common sense of AIDS-to-development, and that this has occurred despite evidence that the 
causal relationship between poverty and AIDS is far more complex that merely being poor 
makes you more likely to contract HIV’ (Gould 2009), or that AIDS is the principal driver of 
global poverty. Nevertheless, investing heavily in AIDS has come to be a central pillar of 
international development efforts, working on the basis that investing in HIV/AIDS 
prevention, treatment and care helps to address one of the most significant obstacles to 
development (although, as Katz noted in relation to the CMH, this can in itself obscure some 
of the other fundamental causes of poverty and underdevelopment). 
Indeed, both the privileged status of AIDS and its ‘exceptional’ status with regards to 
development have recently come under challenge, both intellectually and in policy terms. For 
example, Shiffman (2008) traces how international aid for HIV/AIDS has had a number of 
distorting effects on other areas of health aid and development, claiming that this has led to 
some loss of focus on some other key global health challenges, including stagnation in 
funding for strengthening health systems. Roger England (2008), on the other hand, takes a 
more radical approach which highlights that whilst AIDS accounts for 3.7% of global 
mortality ‘it receives 25% of international healthcare aid’, a fact which he sees as distorting 
international health funding; as out of proportion; as having the potential to cause disruption 
to (fragile) national health systems; and as a reason for immediate institutional reform in the 
shape of dismantling UNAIDS. In policy terms, as we discuss below, there has recently 
emerged a pervasive feeling that political attention is shifting away from AIDS and towards 
some other pressing global health and development issues.  
It is clear that the AIDS community, and major AIDS institutions, in responding to 
these challenges are seeking ways in which to shore up the special status of AIDS. As we 
argue in the next section, they are doing so in a way which mobilises the established virtuous 
circle arguments, but which both repackages them for the contemporary policy context (in 
which there is a global emphasis on the MDG deadline of 2015) and also makes some 
significant concessions to the kinds of criticisms of ‘silo-based’ global health strategies which 
we have examined here. 
The AIDS plus MDGs Approach 
The ‘AIDS plus MDGs’ approach has to date been driven by UNAIDS and UNDP, with 
discussion on it beginning at the UNAIDS Committee of Co-sponsoring Organizations in 
2009 (UNDP/UNAIDS 2011, p.  23). The concept became a more prominent feature of 
international discussions in 2010, and was a particular focus for UNAIDS in the context of 
the May 2010 World Health Assembly and the September 2010 MDG review summit. At the 
latter event, there was a widespread perception that other health issues, not least maternal 
health and malaria, were beginning to threaten AIDS’ dominance of the policy agenda. 
During the summit, UNAIDS, along with the governments of China, South Africa and 
Nigeria, co-hosted a side event on the ‘AIDS plus MDGs’ approach which included keynote 
speakers from a number of heavily affected countries as well as WHO Director-General 
Margaret Chan and Michel Sidibé, Executive Director of UNAIDS (UNAIDS 2010a). 
UNAIDS has subsequently continued to promote the AIDS plus MDGs approach. 
The AIDS plus MDGs approach highlights the intersections between AIDS (the focus 
of MDG6) and the other MDG targets, making the case that:  
AIDS and the other MDGs are fundamentally interrelated. An effective AIDS response is 
critical to the achievement of the other MDGs, particularly in high-prevalence areas. 
Conversely, making a substantial impact on the AIDS pandemic depends on 
simultaneously advancing progress in other MDG areas. (Kim et al. 2011, p. 144) 
The crux of the argument is that an approach to AIDS which views it within the context of 
the MDGs as a whole would provide ‘an opportunity to respond in a fresh way to the 
changing context and to accelerate progress in achieving the MDGs’ (UNAIDS 2010b, p. 3). 
In the previous section we discussed amongst other things the fact that the central 
place AIDS has enjoyed in global health and development policy seems to have been coming 
increasingly under threat. In this section we interpret the AIDS plus MDGs approach as an 
attempt by key AIDS institutions to respond to this challenge by focusing in particular on the 
ways in which they frame AIDS as a development issue, and where this framing draws or 
deviates from, established approaches to understanding and doing international development. 
We argue that key parts of the international AIDS community appear to be adjusting their 
approach to the virtuous circle. The adjustment is subtle but significant. Rather than only 
stressing the positive effects of investing in AIDS on other areas of development, the 
approach examined here supplements this with a more sensitive view of the positive effects 
on AIDS of wider investment in other MDG areas (education, maternal health, poverty 
alleviation and so on) as well as acknowledging the wider structural determinants of HIV and 
health status. The agenda forwarded by the AIDS plus MDGs approach therefore presents 
itself as a recontextualisation of AIDS’ place within development and reframes the AIDS-
development relationship in bidirectional and interdependent terms. AIDS is still cast as one 
of many obstacles to development, yet structural factors associated with underdevelopment 
are also included in the frame as obstacles to real progress on AIDS. This contrasts with the 
approach critiqued by Katz in the previous section, since it advocates for a more holistic view 
of international development efforts.  
This shift in thinking, and the AIDS plus MDGs which it has engendered, can best be 
seen as a response (or policy adjustment) to a number of structural and contextual changes in 
the political and economic environment within which these institutions now find themselves. 
First, as Whiteside (2009) has indicated, the period from 2006 onwards has witnessed an 
unprecedented challenge to AIDS exceptionalism with regard to development policy and aid, 
or AIDS’ dominance of those policy agendas. Debates surrounding the distorting role of 
AIDS on overall health and development spending; the desirability of shifting investment to 
health systems and Health Systems Strengthening; concerns about the absorptive capacity of 
countries; a growing belief that the global AIDS response may be reaching the limits of what 
can be achieved without taking a broader approach; and changing ideas about the nature of a 
‘sustainable’ global response have all played a part in generating new thinking and changing 
priorities. The AIDS plus MDGs approach also explicitly seeks to address the changing 
economic context of international development, not least the impact of the global financial 
crisis and apparent changes in political prioritization. The AIDS plus MDGs approach should 
properly be viewed as an attempt to provide a response to many of these criticisms and 
problems (which have come from both within and outside the AIDS policy community), but 
does so in a manner which seeks to limit damage to AIDS’ status as a top tier health and 
development issue and provides an adjusted rationale for continued (and indeed increased) 
investment in AIDS. 
The remainder of this section provides an analysis of two of the key policy documents 
laying out the AIDS plus MDGs approach, presenting evidence of both continuity and change 
vis-à-vis previous framings of health, AIDS and development. The first is a UNAIDS 
document entitled AIDS plus MDGs: synergies that serve people (UNAIDS 2010b). The 
second is a 2011 UNAIDS/UNDP publication entitled The ‘AIDS and MDGs’ Approach: 
what is it, why does it matter, and how do we take it forward? (UNDP/UNAIDS 2011)
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version of the latter paper authored by members of the United Nations Development 
Program’s (UNDP) HIV/AIDS Group was also published in the journal Third World 
Quarterly (Kim et al. 2011). The two documents clearly overlap in drawing from the same 
well-established discourses which link AIDS, poverty and development; in particular drawing 
on, or resonating with, the background ‘common sense’ notion of the virtuous circle. 
However, both documents also show strategic adjustment to changing circumstances and 
policy critiques that accrued during the first decade of the MDG period. We begin by laying 
out some of the areas of continuity before moving on to examine areas of change. In our 
conclusion we discuss the implications of this shift for our understanding of framing in global 
health, in particular how actors and their environment interact. 
The clearest areas of continuity lie in the documents’ situation of AIDS as being 
fundamentally linked to development. It is particularly notable that both documents place a 
considerable emphasis upon the structural determinants of HIV and the need for HIV and 
development policy to be viewed holistically. For example, the UNAIDS document argues 
that: 
To be effective and sustainable, the AIDS response, working strategically with other 
development partners, must continue and ramp up its push for positive social change and 
become more holistic in approaching these drivers and the companion health, 
development and rights challenges that affect and are affected by the epidemic—like 
maternal and child health, gender violence and inequality, universal education and 
infectious diseases like tuberculosis. AIDS responses must reach beyond the artificial 
boundaries of a single disease. (UNAIDS 2010b, p. 3) 
However, little attempt is made in the documents to explain what is meant by ‘development’, 
other than a focus on the other MDGs. Perhaps this MDG focus is natural enough since, as 
we noted above, the MDGs have formed a blueprint for health and development policy for 
the last decade, but again we find that the ‘AIDS plus MDGs’ approach collapses this broader 
(and highly contested) development paradigm into a narrow focus on MDG attainment. 
Obviously, this evades the complexity of defining development and clarifying the myriad 
dimensions of its relationship with HIV/AIDS, and obscures the highly politicised terrain 
which the relationship has traditionally occupied. However, as is often the case with the use 
of a contested concept, the use of development nonetheless introduces a tension. Whilst the 
AIDS plus MDGs approach embodies in theory a clear recognition of the myriad links 
between HIV and development more broadly, these documents were both written within a 
policy context defined by – and therefore naturally focusing upon – the eight internationally-
agreed MDG goals rather than a more comprehensive understanding of development.  
Also evident throughout the documents is the well-established ‘common sense’ notion 
of a relationship between health and development, and the claim that investing in AIDS has 
spill-over effects for other MDGs, creating a virtuous circle in which both AIDS and other 
development problems are addressed.  
An effective AIDS response is critical to the achievement of the other MDGs, 
particularly in high prevalence areas. (UNDP/UNAIDS 2011, p. 9) 
This general argument is supplemented in both documents through the use of case studies to 
show the broader impacts of AIDS investments in practice in countries such as Rwanda, 
Ethiopia and Nigeria. Both documents also provide examples of a number of the ways in 
which HIV investments benefit the other MDGs. The UNDP document in particular provides 
a wealth of evidence of this impact on a number of the other MDGs (p. 21), in each case 
providing references to studies which evidence the link. This cross-cutting role of AIDS is 
also strongly in evidence in the final recommendations of the UNAIDS, emphasises that 
status in order to make clear the need to retain AIDS as a global health priority and ‘for 
countries to sustain and increase their financial contributions to HIV’ (UNAIDS 2010b, p. 
10). Given the origins and purpose of the document it is perhaps unsurprising that, even with 
a more balanced and nuanced approach to the relationship (discussed below), there remains a 
subtle but tangible asymmetry to the circular AIDS-MDGs argument which privileges the 
contribution of AIDS to the other MDGs over and above the inverse. It seems that special 
pleading is natural here (given the institutional origins of the AIDS plus MDG approach), but 
it is also certain that the appeal to old logics in ostensibly new (and incommensurable) frames 
reflects the fact that a particular ‘common sense’ can have life well beyond its original 
purpose.  
Despite these continuities, the change in rhetoric in these documents is striking. They 
seek to address some of the critiques of the AIDS response and its broader developmental 
effects, whilst continuing to forward the case for investment in AIDS as a key part of MDG 
progress. Both documents are clear that the AIDS response can no longer afford to ‘operate in 
isolation’ (and this is a rather frank admission that it previously did). This is a significant 
shift from older narratives of AIDS exceptionalism, and can be seen as a significant 
concession by the AIDS policy community to some of its critics, as well as a giving of 
ground vis-à-vis the wider exceptionalism of AIDS with respect to development progress. 
Thus the AIDS plus MDGs approach seizes an opportunity to integrate AIDS approaches to a 
more holistic notion of health, and subsequently to reconnect the health agenda with a 
broader development paradigm. In a strategic sense this repositioning reflects the fact there 
seems to be little or no choice but to harness the fortunes of the disease (not least in resource 
terms) to emergent issues and priorities.  
Thus the AIDS plus MDGs approach does not focus solely on the beneficial spill-over 
effects of AIDS investment, but places an almost equal emphasis on the ‘two-way 
relationship’ between HIV and the other MDGs, wherein AIDS can and does benefit from 
investment in areas such as education, gender equality, maternal health and food and 
nutrition, amongst others. The documents are replete with phrases such as ‘cross-MDG 
synergy’, ‘ending AIDS isolationism’, breaking down the ‘artificial boundaries of a single 
disease’, or synergies which ‘flow both ways’ and so on. Considering the asymmetric nature 
of the virtuous circle which we identified in the previous section, and the narrow focus on 
select diseases which underpinned the MDG blueprint, it is possible to see this emphasis on 
the two-way relationship between AIDS and the other MDGs as an attempt to address both 
the asymmetric nature of the circle and acknowledge the shortcomings of the silo-based 
approaches to development aid which have dominated. The AIDS plus MDGs proposal is not 
only ‘investing in health (AIDS) for development’, but simultaneously calling for ‘investing 
in (other areas of) development for health’.  
 However, a tension is evident here between the rhetoric on cross-MDG synergy and a 
continuing (although less explicit) assumption of AIDS’ exceptional status. If all of the 
MDGs have mutually-reinforcing relationships, why start with AIDS? In theory, emphasising 
cross-MDG synergy could actually undermine the AIDS plus MDGs strategy since, when 
taken to its logical conclusion (i.e. suggesting the possibility of synergy between all MDGs, 
not just HIV and the other MDGs), it provides a basis for further integrating the MDGs into a 
more holistic programme, rather than justifying AIDS as a starting point or the basis of a 
cross-cutting approach. If the aim of ‘AIDS plus MDGs’ is to secure AIDS’ position vis-à-vis 
other development issues, the logic presented seems to suggest that a similar exceptionality 
argument could in principle be used in support of alternative prioritisations by the advocates 
of, say, education or maternal health. Indeed, even more fundamentally, the emphasis on 
cross-MDG synergy could be read as a critique of the entire MDG project, suggesting that the 
approach of isolating specific issues, setting  goals and  targets around them, and the silo-
based responses which have resulted, is itself is to blame for MDG underachievement. Would 
it not be rational to fold in other areas of development and health into such a synergistic 
project, such as sanitation or health systems? The fact is, the MDGs were about the selection 
of a small number of development priorities. The problems inherent in that approach, which 
have long been discussed, are now becoming impossible to ignore. If the AIDS plus MDGs 
approach is accepted as a broader critique of this, then a radical restructuring of international 
development efforts in the post-2015 era could follow, which would extend the outlined 
synergetic approach whilst rejecting the hierarchy of particular health in development issues 
which results in their selection as targets over others.  
However, notwithstanding the possible aforementioned interpretations of the 
approach, both documents do proceed from an assumption that in some ways AIDS 
constitutes a natural starting-point for understanding the relationships between all MDGs. In 
part this is no doubt a legacy of AIDS exceptionalism and a natural result of the mandates of 
the institutions behind the AIDS plus MDGs approach.  But it is also the product of a view 
that the massive global focus on AIDS over the past decade has generated some important 
lessons which can be applied to other MDGs. The documents go to considerable length to 
explain the ways in which some of the key successes of the history of the global AIDS 
response should pollinate approaches to the other MDGs, especially with regard to the 
centrality of human rights, the mobilization of civil society and ways of galvanizing political 
will and resources. In the words of the UNAIDS document 
Investing strategically to address multiple MDGs, and releasing the power, capacity and 
innovation of the AIDS movement, may provide one of the best opportunities to “do the 
MDGs” differently. (UNAIDS 2010b, p. 1) 
 
There is also another notable shift evident in the emphasis on the demedicalisation of the 
AIDS response and the need to engage more broadly with the underlying social and economic 
determinants of health. Claiming to learn the lessons from the history of the response to 
AIDS, the UNDP document notes that:  
The most successful programmes have combined biomedical technologies and 
behavioural interventions with multi-sectoral strategies that address human rights and the 
underlying socio-economic conditions that render a population more vulnerable to 
infection. It is these multi-sectoral strategies that are at the heart of UNDP’s mandate on 
AIDS, the new UNAIDS Outcome Framework and the MDGs themselves. 
(UNDP/UNAIDS 2011, p. 6) 
Of course, this goes to the heart of at least 10 years of criticism of the manner in which 
vertical disease-specific programmes, including AIDS, have pursued heavily biomedically-
oriented approaches. As one aspect of this, the debate over the appropriate balance between 
treatment and prevention has remained unabated for many years, There have been recent 
signs of a move back towards a greater emphasis on prevention, not least in recognition of the 
fact that it is increasingly evident that we cannot ‘treat our way out’ of the AIDS crisis. There 
are signs in the AIDS plus MDGs approach of this subtle shift back towards prevention, 
broadly understood: 
Exacerbating the sense of crisis has been the limited efficacy of conventional biomedical 
and public health approaches, the bulwarks against disease throughout the 20th century. 
While an expanding array of biomedical tools (e.g., condoms and antiretroviral drugs), 
behavioural approaches, and increasingly, structural approaches (what has been termed 
‘combination prevention’) have yielded important progress, they have ultimately been 
unable to halt the epidemic’s course over the past 30 years. ... It is clear that health sector 
interventions and biomedical technologies (either existing or in development) alone are 
inadequate to meet the challenge of the AIDS pandemic. (UNDP/UNAIDS 2011, p. 3) 
This also ties in with the critique of the short-term nature of contemporary select disease-
specific approaches and with discussions around a redefined understanding of 
‘sustainability’, one which is based not on the goal of self-sufficiency of domestic health 
systems, but rather on domestic efforts being supplemented by a predictable and reliable level 
of international support (Ooms et al. 2010). As Ooms et al. have noted (2009), the global 
AIDS response was to a great extent responsible for bringing about this new thinking (or 
reframing of what sustainability can mean), and Michel Kazatchkine, Executive Director of 
the Global Fund, has been a high-profile supporter of viewing sustained international support 
as central to sustainability. The significant scale-up AIDS treatment has led to millions more 
people receiving the drugs they need and, as noted above, this has only been possible because 
the massive international investment, especially from the G8. There exists a clear (and 
widely-recognised) ethical imperative to continue to provide these treatments to those who 
have begun them for the remainder of their lives. Sustaining this level of provision – even 
without adding to the numbers receiving treatment – will require a continued and reliable 
commitment from international donors. The AIDS plus MDGs approach is clearly influenced 
by these developments, and explicitly seeks to make a case for a shift ‘from emergency mode 
to a long-term response.’  (UNDP/UNAIDS 2011, p. 8). 
The AIDS plus MDGs approach, therefore, is not merely reactive to the current 
political and economic context, but is also future-looking, seeking to secure AIDS’ place in 
the future of international development and to ensure that the global AIDS response is 
sustainable in the long term. 
Conclusion 
Here we offer some concluding thoughts which examine what the AIDS plus MDGs 
approach can tell us about the changing landscape of global health governance, the position 
of AIDS within it, and the use of framing in global health. It is clear from the preceding 
discussion that the AIDS plus MDGs approach represents a significant modification of old 
narratives, despite building upon a well-established framing of AIDS as a development issue. 
Rather than being presented as the route for wider development and policy alleviation – with 
AIDS’s status in global health policy and the MDGs arguably being ‘exceptional’ – the 
rhetoric of the AIDS plus MDGs approach indicates a move in the direction of ‘de-
exceptionalisation’. In doing so, the proponents of the AIDS plus MDGs approach within the 
AIDS community appear to be strategically repositioning AIDS as a co-dependent of a wider 
development project, stressing AIDS’ dependency on broader development progress rather 
than merely its contribution to it, a move which is quite unexpected and unprecedented. 
The framers are clearly responding to a changing political and economic context, and 
indeed this fact is explicitly stated within the documents themselves. Awareness of the impact 
of the financial crisis and the waning political traction of AIDS as a priority issue vis-à-vis 
‘rising’ health issue areas looms large over both documents. Nonetheless, also evident is a 
response to some of the criticisms of the AIDS response, in particular complaints over the 
selective disease-focussed nature of the MDGs, short-termism, the biomedical bias of current 
responses, and the need to escape from the silo-based nature of discrete development 
interventions. What can this changing AIDS-development narrative tell us about framing in 
global health more generally?  
First, this case highlights the fact that framing is a strategic activity, used in order to 
forward particular claims about prioritisation, and in order to secure (or in this case maintain) 
resources. It is clear that the AIDS community is not only conscious of the present 
vulnerability of AIDS to competing priorities, but is capable of responding and adapting to 
that context. It is clear that the MDG period has been characterised by reflection not only as 
to the efficacy of the targets themselves, but as to how to achieve them. Lessons have been 
learned from both successes and failures, not least with the relationship between the three 
health-related MDGs and the health systems on which they depend. Attitudes within the 
AIDS community, in particular over the desirability of closer collaboration with other sectors, 
have gradually been changing and in the AIDS plus MDGs approach are set out clearly as a 
forward-looking policy proposal. 
Second, frames are malleable as they often draw on contested concepts – in this case 
‘development’ – with the meaning of the particular concept being taken as ‘common sense’. 
In framing AIDS as a development issue, the proponents of the AIDS plus MDGs approach 
avoid being drawn into a convoluted debate over the meaning of ‘development’. In both 
sections of this paper we have seen how ‘development’ has been captured in particular ways, 
leading to certain dominant policy frameworks, most notably the MDGs, setting the terrain 
on which interventions and action on ‘development’ are carried out. Katz is correct to 
describe this as a blueprint, both in the sense that it ‘governed’ development and health policy 
in the MDG period, but also in the sense that the blueprint had real ideational power. In the 
relationship between AIDS and development, the documents analysed here appear to suggest 
a shift from ‘AIDS to development’ to ‘AIDS and development’, but despite the rhetoric 
about the need to engage with broader structural determinants, the focus in practice is on the 
relationship with the other seven MDGs. The question remains, of course, as to whether this 
call for partnership and ‘de-silo-isation’ is merely a rhetorical strategy for securing continues 
resources for AIDS amongst other development priorities, or whether is it a genuine case of 
‘lessons learned’, since frames rarely ‘start from scratch’ and the AIDS plus MDGs approach 
relies for its ideational power on a longer history of the framing of health (and AIDS) as a 
development issue. 
It is too soon to tell whether the AIDS plus MDGs approach will have a genuinely 
transformative policy impact, despite the significant change in rhetoric.  Whilst the ‘new’ 
approach could be characterised as a rearguard action of a community feeling under siege, 
there are also signs that it is looking further to the future, not least in terms of the looming 
end of the MDG period in 2015, and ongoing discussion over future development targets.  
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Notes 
(1) This paper draws on insights on AIDS as a development issue gathered during 
interviews conducted by the authors in 2010-2011 with key individuals and 
organisations in London, New York, Washington DC and Geneva. 
(2) NACs were heavily promoted by the World Bank and UNAIDS as the appropriate 
form of national response mechanism (Putzel 2004). They stand outside of the 
national Ministry of Health and bring together representatives from across 
government departments as well as civil society and the private sector. 
(3) Roger England is one of the most high-profile critics of AIDS exceptionalism: e.g. 
England 2008. 
(4) To take one example (and it is a major one), in 2010 the President’s Emergency Plan 
for AIDS Relief (PEPFAR) accounted for over 70% of the overall US global health 
budget.  
(5) For clarity this is referred to in this paper as ‘the UNDP document’.   
References  
Bayer, R., 2001. Public Health Policy and the AIDS Epidemic – An End to HIV 
Exceptionalism? New England Journal of Medicine, 324, 1500-1504. 
 
Commission on Macroeconomics and Health, 2001. Macroeconomics and Health: Investing 
in Health for Economic Development. Report of the Commission on Macroeconomics 
and Health. Geneva: WHO. 
 
Das, P. and Samarasekera, U., 2008. ‘What Next for UNAIDS?’ The Lancet, 372 (9656), 
2099-2102.  
 
England, R., 2008. The writing is on the wall for UNAIDS. British Medical Journal, 336 
(7652), 1072. 
 
Faubion, T., Paige, S.B. and Pearson, A.L., 2011. Co-opting the Global Health Agenda: The 
Problematic Role of Partnerships and Foundations. In: S. Rushton and O.D. Williams 
(eds), Partnerships and Foundations in Global Health Governance, Basingstoke: 
Palgrave Macmillan. 
 
Katz, A., 2004. The Sachs Report: Investing in health for economic development: or 
increasing the crumbs from the rich man’s table? Part I. International Journal of 
Health Services, 34 (4). 751-773. 
 
Katz, A., 2005. The Sachs Report: Investing in health for economic development: or 
increasing the crumbs from the rich man’s table? Part II. International Journal of 
Health Services, 35 (1), 171-188. 
 
Kim, J., Lutz, B., Dhaliwal, M. and O’Malley, J., 2011. The ‘AIDS and MDGs’ Approach: 
what is it, why does it matter, and how do we take it forward? Third World Quarterly, 
32 (1), 141-163. 
 
Lisk, F., 2010. Global Institutions and the HIV/AIDS Epidemic. London: Routledge. 
 
Mushkin, S., 1962. Health as an investment. Journal of Political Economy, 70 (5), 129-157. 
 
Ollila, E., 2005. Global Health Priorities – Priorities of the Wealthy? Globalization and 
Health, 1 (6). 
 
Ooms, G., Hill, P.S., Hammonds, R.,Van Leemput, L., Assefa Y., Miti, K. and Van Damme, 
W., 2010. Applying the Principles of AIDS ‘Exceptionality’ to Global Health: 
Challenges for Global Health Governance. Global Health Governance 4 (1), 1-9. 
 
Piot, P., Greener, R. and Russell, R., 2007. Squaring the Circle: AIDS, Poverty, and Human 
Development/ PLoS Medicine, 4 (10), e314.  
 
Putzel, J., 2004. The Global Fight Against Aids: How Adequate Are The National 
Commissions? Journal of International Development, 16, 1129-1140  
 
Rushton, S., 2010. Framing AIDS: Securitization, Development-ization, Rights-ization’. 
Global Health Governance, 4 (1), 1-17. 
 
Shiffman, J., 2008. Has donor prioritization of HIV/AIDS displaced aid for other health 
issues? Health Policy and Planning, 23 (2), 95-100. 
 
Shiffman, J., 2009. A social explanation for the rise and fall of global health issues, Bulletin 
of the World Health Organization, 87, 608-613.  
 
Sridhar, D. and Batniji, R., 2008. Misfinancing global health: a case for transparency in 
disbursements and decision making. The Lancet, 372 (9644), 1185-1191. 
 
UNAIDS, 2010a. Media Advisory: AIDS plus MDGs: Delivering results towards our shared 
commitments. Available at: 
http://www.un.org/en/mdg/summit2010/pdf/20100916MA_MDG_Events_Final3.pdf 
[Accessed 20 December 2011].  
 
UNAIDS, 2010b. AIDS plus MDGs: synergies that serve people. Available at:  
http://data.unaids.org/pub/Report/2010/jc1998_aidsplusmdgs_en.pdf [Accessed 20 
December 2011].  
 
UNDP, 1996. Human Development Report 1996. Oxford: Oxford University Press. 
 
Whiteside, A., 2009. Is AIDS Exceptional? aids2031 Working Paper No. 25. Available at: 
http://www.aids2031.org/pdfs/aids%20exceptionalism_paper25.pdf  [Accessed 21 
December 2011].  
 
UNDP/UNAIDS, 2011. The ‘AIDS and MDGs Approach: What is it, why does it matter, and 
how do we take it forward? New York: UNDP. Available at: 
http://www.unaidsrstesa.org/print/464 [Accessed 21 December 2011].   
 
Williams, O.W and Rushton, S., 2011. Are the ‘good times’ over? Looking to the future of 
Global Health Governance, Global Health Governance, forthcoming, Fall 2011. 
Available at: http://blogs.shu.edu/ghg/2011/11/21/are-the-%E2%80%98good-
times%E2%80%99-over-looking-to-the-future-of-global-health-governance/ 
[Accessed 20 December 2011].  
 
World Bank, 1993. World Development Report 1993: Investing in Health. Washington DC: 
World Bank. 
 
 
 
 
 
 
 
